Diabetes Mellitus, Type 2 Clinical Trials in Seattle, Washington

4 studies are recruiting for diabetes mellitus, type 2 in Seattle, Washington right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes

    The purpose of this clinical study is to look into how well a study medicine called CagriSema helps children and adolescents living with diabetes lower their blood sugar and body weight. The study has 2 parts: in the first part participant will get either CagriSema or placebo, and in the second par…

    Stage
    Phase 3
    Ages
    10 to 18
    Site
    Seattle Children's Research Institute, Seattle, Washington
    Locations
    58 in total
    Run by
    Novo Nordisk A/S

    See if you can join NCT07282613 on ClinicalTrials.gov

  2. A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events

    TRANSFORM is a prospective, randomized, open blinded endpoint (PROBE), event-driven, pragmatic trial in patients who are at increased risk for atherosclerotic cardiovascular (CV) disease but with no known symptomatic CV disease. The trial tests the hypothesis that a Cleerly Coronary Artery Disease …

    Stage
    Not phased
    Ages
    55 and older
    Site
    University of Washington, Seattle, Washington
    Locations
    125 in total
    Run by
    Cleerly, Inc.

    See if you can join NCT06112418 on ClinicalTrials.gov

  3. Effects of High-Resistance Inspiratory Muscle Strength Training on Cardiorenal and Vascular Function in Youth and Young Adults With Type 2 Diabetes

    High-resistance, short-duration inspiratory muscle strength training (IMST) is a novel lifestyle intervention involving 30 inhalations against a resistive load which requires only ~5 min/day and is thus ideal for youth with T2D (Y-T2D). Investigators seek to 1: assess changes in casual and 24-hr SB…

    Stage
    Not phased
    Ages
    14 to 40
    Site
    Seattle Children's Hospital, Seattle, Washington
    Locations
    2 in total
    Run by
    Seattle Children's Hospital

    See if you can join NCT06936670 on ClinicalTrials.gov

  4. Effects of Semaglutide on Intracranial Blood Flow and Brain-Barrier Permeability in Type-2 Diabetes

    A human subjects research study, the primary purpose of which is to assess the EFFECTS OF SEMAGLUTIDE ON INTRACRANIAL BLOOD FLOW AND BLOOD-BRAIN BARRIER PERMEABILITY IN TYPE-2 DIABETES (T2D) through testing of the intervention on patients in a clinical setting. The study will randomize subjects wit…

    Stage
    Phase 4
    Ages
    40 to 65
    Site
    University of Washington - Harborview Medical Center, Seattle, Washington
    Run by
    University of Washington

    See if you can join NCT05780905 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.